Results 51 to 60 of about 3,825,971 (175)

Catheter Ablation or Surgical Therapy in Severe Atrial Functional Mitral Regurgitation Caused by Long‐Standing Persistent Atrial Fibrillation—Propensity Score Analysis

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background There is no consensus on the treatment strategy for patients with severe atrial functional mitral regurgitation combined with heart failure (HF), with a lack of comparative studies in patients with long‐standing persistent atrial fibrillation ...
Qing Ye, Yuqi Li, Wenbo Zhang, Yichen Zhao, Cheng Zhao, Zonglin Li, Fei Li, Yan Yao, Jiangang Wang   +8 more
doaj   +1 more source

Functional anatomy and echocardiographic assessment in secondary mitral regurgitation

, 2022
BACKGROUND: Mitral valve apparatus is complex and involves the mitral annulus, the leaflets, the chordae tendinae, the papillary muscles as well as the left atrial and ventricular myocardium. Secondary mitral regurgitation is a consequence of regional or
Nogara, Angela, Zambelli, Giulia, Coco, Valeria Lo, Fattouch, Khalil, Minacapelli, Alberto   +4 more
core   +1 more source

Cardiac remodelling in the era of the recommended four pillars heart failure medical therapy

ESC Heart Failure, Volume 12, Issue 2, Page 1029-1044, April 2025.
Abstract Cardiac remodelling is a key determinant of worse cardiovascular outcome in patients with heart failure (HF) and reduced ejection fraction (HFrEF). It affects both the left ventricle (LV) structure and function as well as the left atrium (LA) and the right ventricle (RV).
Giada Colombo, Tor Biering‐Sorensen, Joao P. Ferreira, Carlo Mario Lombardi, Andrea Bonelli, Andrea Garascia, Marco Metra, Riccardo M. Inciardi   +7 more
wiley   +1 more source

Mitral valve surgery for functional mitral regurgitation: prognostic role of tricuspid regurgitation☆ [PDF]

European Journal of Cardio-Thoracic Surgery, 2009
The purpose of this study was to evaluate the impact of untreated moderate-or-more functional tricuspid regurgitation (FTR) on mid-term outcome of patients with functional mitral regurgitation (FMR) undergoing mitral valve surgery (MVS).From January 1988 to April 2003, 165 patients having FMR underwent MVS with untreated FTR.
DI MAURO, MICHELE, BIVONA A, IACÒ A. L, CONTINI M, GAGLIARDI M, VARONE E, GALLINA, Sabina, CALAFIORE A. M.   +7 more
openaire   +2 more sources

Interventional therapies for chronic heart failure: An overview of recent developments

ESC Heart Failure, Volume 12, Issue 2, Page 1081-1094, April 2025.
Abstract Heart failure (HF), the final manifestation of most cardiovascular diseases, has become a major global health concern, affecting millions of individuals. Despite basic drug treatments, patients present with high morbidity and mortality rates. However, recent advancements in interventional therapy have shown promising results in improving the ...
Bingchen Guo, Si Shi, Yutong Guo, Jie Xiong, Bo Wang, Zengxiang Dong, Dianyu Gao, Yingfeng Tu   +7 more
wiley   +1 more source

Outcomes of Mitral Valve Surgery for Atrial Functional Mitral Regurgitation vs Ventricular Functional Mitral Regurgitation

European Journal of Cardio-Thoracic Surgery
Abstract Objectives Atrial functional mitral regurgitation (AFMR) is a unique category of functional mitral regurgitation (FMR), and surgical outcomes compared to traditional ventricular FMR (VFMR) are limited. This study compared long-term outcomes of mitral valve surgery (MVS) for patients with AFMR
Sophia R Pyeatte, Mehran Rahimi, Maxwell C Braasch, Theodore Marghitu, Marci Damiano, June He, Alexander A Brescia, Ralph J Damiano, Nicholas Kouchoukos, Tsuyoshi Kaneko   +9 more
openaire   +3 more sources

Transendocardial injection of expanded autologous CD34+ cells after myocardial infarction: Design of the EXCELLENT trial

ESC Heart Failure, Volume 12, Issue 2, Page 1455-1463, April 2025.
Abstract Aims The extent of irreversible cardiomyocyte necrosis after acute myocardial infarction (AMI) is a major determinant of residual left ventricular (LV) function and clinical outcome. Cell therapy based on CD34+ cells has emerged as an option to help repair the myocardium and to improve outcomes.
Jerome Roncalli, François Roubille, Nicolas Meyer, Giulio Pompilio, Lionel Leroux, Philippe Henon, Guillaume Trebuchet, Anthony Criquet, Matthieu de Kalbermatten, Eric Saloux, Alain Manrique, Pierre‐Yves Marie, Deepak L. Bhatt, Scott D. Solomon, Gilles Montalescot, David E. Newby, Faiez Zannad, on behalf of the EXCELLENT Trial Investigators   +17 more
wiley   +1 more source

Left atrial function in uraemic patients: Four‐dimensional automatic left atrial quantitative technology study

ESC Heart Failure, Volume 12, Issue 2, Page 1316-1325, April 2025.
Abstract Objective This study aimed to evaluate the utility of left atrial volume and function in uraemic patients using four‐dimensional automatic left atrial quantification (4D auto LAQ) technology. Methods Thirty‐four undialysed uraemic patients (U‐ND group), 60 dialysed uraemic patients (U‐D group), and 32 healthy volunteers (N group) were enrolled
Bing Li, Meihua Chen, Xuning Huang
wiley   +1 more source

Impact of Peripheral Artery Disease in Patients With Heart Failure Undergoing Transcatheter Mitral Valve Repair: The COAPT Trial

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2023
Background Peripheral artery disease (PAD) and heart failure (HF) often coexist. Whether PAD influences outcomes of transcatheter mitral valve repair (TMVr) in patients with HF and severe secondary mitral regurgitation is unknown.
Bahira Shahim, David J. Cohen, Ori Ben‐Yehuda, Björn Redfors, Saibal Kar, D. Scott Lim, Suzanne V. Arnold, Yanru Li, JoAnn Lindenfeld, William T. Abraham, Michael J. Mack, Gregg W. Stone   +11 more
doaj   +1 more source

Long-term prognosis of mild functional tricuspid regurgitation after mitral valve replacement

, 2014
Objective: Functional tricuspid regurgitation (FTR) is the most common type of tricuspid insufficiency and occurs approximately in 30% of patients with mitral valve disease.
Hatemi, Ali Can, Bakuy, Vedat, Kucukoglu, Serdar, Bulut, Gulsum, Kilickesmez, Kadriye, Gursoy, Mete, Ince, Nurhan   +6 more
core   +1 more source